Oncosec just made a substantial deal and its stock has been trading much much higher. So yah I don't get what you are saying here at all you are totally wrong.
As for Conatus it was a NASH biotech and a gamble. It didn't pay off. Not all biotechs end up being successful. But I'm sure you as being some type of guru in biotech would know that.
News 
Market Data 
Discover 
